drugset / Trial / NCT06972888
A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the efficacy and safety of AC-201 tablets compared with placebo in subjects with moderate-to-severe plaque psoriasis
Timeline
- Start
- 2024-04-23
- Primary completion
- 2025-03-07
- Completion
- 2025-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diacerein | Small molecule | — | Oral |